Patrick Zenner
Fortune : 77 915 $ au 31/08/2026
Fortune : 77 915 $ au 31/08/2026
M. Patrick J. Zenner est un administrateur indépendant de Selecta Biosciences, Inc. et un président non exécutif de West Pharmaceutical Services, Inc. et un président de l'Université Fairleigh Dickinson. Il est membre du conseil d'administration de Selecta Biosciences, Inc, d'ArQule, Inc, de Biotechnology Innovation Organization, de HealthCare Institute of New Jersey et de Creighton University. M. Zenner a été précédemment employé en tant que directeur indépendant par Par Pharmaceutical Cos, Inc. et en tant que président-directeur général par CuraGen Corp, président par EXACT Sciences Corp, président par ArQule, Inc, président-directeur général par Hoffmann-La Roche, Inc, vice-président et directeur général par Roche Laboratories, Inc, et président-directeur général par Roche Holdings, Inc. Il a également été membre du conseil d'administration de Sciele Pharma, Inc, XOMA Ltd, Dendrite International, Inc, Geron Corp, Endotis Pharma SARL, Neuro3D SA, NextWave Pharmaceuticals, Inc, Par Pharmaceutical, Inc, Pharmaceutical Research & Manufacturers of America et Praecis Pharmaceuticals, Inc. Il a obtenu son diplôme de premier cycle à l'université Creighton et un MBA à l'université Fairleigh Dickinson.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,03% | 14/04/2026 | 8 396 ( 0,03% ) | 77 915 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | Directeur/Membre du Conseil | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Creighton University
Creighton University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Président | 24/05/2022 |
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Develops cardiovascular therapeutics | Directeur/Membre du Conseil | 26/12/2013 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Directeur/Membre du Conseil | 28/09/2012 |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Directeur/Membre du Conseil | 01/01/2012 |
| ARQULE, INC. | Président | 01/01/2012 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 23 |
|---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
Dendrite International, Inc.
Dendrite International, Inc. Packaged SoftwareTechnology Services Provides sales force software products and support services | Technology Services |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Health Technology |
EXACT Sciences Corp.
EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products to treat the central nervous system | Health Technology |
Creighton University
Creighton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Develops cardiovascular therapeutics | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Markets and sells pharmaceutical medications | Distribution Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national